Medtronic plc — Director's Dealing 2021

Jun 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2021-05-28

Reporting Person: Liddicoat John R (EVP & President of Americas)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-28	Ordinary Shares	M	17095	$78.00	Acquired	59646	Direct
2021-05-28	Ordinary Shares	M	1283	$78.00	Acquired	60929	Direct
2021-05-28	Ordinary Shares	M	1136	$88.06	Acquired	62065	Direct
2021-05-28	Ordinary Shares	M	15142	$88.06	Acquired	77207	Direct
2021-05-28	Ordinary Shares	S	34656	$126.65	Disposed	42551	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-28	Stock Option (Right to Buy)	$78.00	M	17095	Disposed	2025-08-03	Ordinary Shares (17095)	Direct
2021-05-28	Stock Option (Right to Buy)	$78.00	M	1283	Disposed	2025-08-03	Ordinary Shares (1283)	Direct
2021-05-28	Stock Option (Right to Buy)	$88.06	M	1136	Disposed	2026-08-01	Ordinary Shares (1136)	Direct
2021-05-28	Stock Option (Right to Buy)	$88.06	M	15142	Disposed	2026-08-01	Ordinary Shares (15142)	Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2: This balance increased by 562 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan.

F3: These options become exercisable at the rate of 25% of the shares granted per year beginning one year from grant date.